Skip to main content

PAVmed Inc. (PAVM)

NASDAQ: PAVM · IEX Real-Time Price · USD
6.10
+0.02 (0.33%)
After-hours:Oct 15, 2021 7:58 PM EDT
6.08
-0.50 (-7.60%)
At close: Oct 15, 4:00 PM
Market Cap557.77M
Revenue (ttm)n/a
Net Income (ttm)-35.42M
Shares Out82.24M
EPS (ttm)-0.55
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,297,343
Open6.67
Previous Close6.58
Day's Range6.04 - 6.70
52-Week Range1.63 - 9.70
Beta0.23
AnalystsStrong Buy
Price Target9.50 (+56.3%)
Est. Earnings DateNov 4, 2021

About PAVM

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusi...

IndustryHealth Care Equipment & Supplies
IPO DateApr 28, 2016
Employees25
Stock ExchangeNASDAQ
Ticker SymbolPAVM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for PAVmed stock is "Strong Buy." The 12-month stock price forecast is 9.50, which is an increase of 56.25% from the latest price.

Price Target
$9.50
(56.25% upside)
Analyst Consensus: Strong Buy

News

PAVM Stock: One Big Reason Why PAVmed Is Plunging Today

Today, a relatively disappointing start to trading for a PAVmed subsidiary, Lucid Diagnostics, is driving some bearish price action. The post PAVM Stock: One Big Reason Why PAVmed Is Plunging Today appe...

1 day ago - InvestorPlace

Lucid Diagnostics Announces Pricing of Initial Public Offering

NEW YORK--(BUSINESS WIRE)---- $LUCD--Lucid Diagnostics announces pricing of Initial Public Offering.

Other symbols:LUCD
2 days ago - Business Wire

PAVmed Acquires EsophaCap Manufacturer CapNostics LLC

NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today anno...

1 week ago - GlobeNewsWire

PAVmed to Host Digital Health Virtual Investor Event

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed to Host Digital Health Virtual Investor Event, Veris Health: Bringing Digital Health to Cancer Care.

2 weeks ago - Business Wire

Why PAVmed Shares Are Trading Higher Today

PAVmed Inc (NASDAQ: PAVM) is trading higher Thursday after the company announced its majority-owned subsidiary, Lucid Diagnostics, filed a registration statement for a proposed initial public offering. ...

3 weeks ago - Benzinga

These 2 Nasdaq Small Caps Just Got Big Boosts

In a rising market, these companies looked especially impressive.

Other symbols:VERIVIAC
3 weeks ago - The Motley Fool

PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed subsidiary, Lucid Diagnostics, files registration statement for proposed initial public offering.

3 weeks ago - Business Wire

PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development P...

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed subsidiary Veris Health joins Microsoft for startups global program and engages Loka as software development partner.

3 weeks ago - Business Wire

PAVmed to Participate in September Investor and MedTech Conferences

NEW YORK--(BUSINESS WIRE)---- $PAVM--PAVmed to participate in September investor and MedTech conferences.

1 month ago - Business Wire

Why Shares of PAVmed Were Down This Morning

Investors are growing impatient about a planned spinoff.

2 months ago - The Motley Fool

PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results. Conference call to be held today at 4:30 PM EDT.

2 months ago - Business Wire

PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed subsidiary Lucid Diagnostics launches first Lucid test centers. Patients undergoing esophageal precancer testing in Phoenix metro area.

2 months ago - Business Wire

PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference

NEW YORK--(BUSINESS WIRE)---- $PAVM--PAVmed's CEO, Lishan Aklog, will present a corporate update at the 41st Annual Canaccord Genuity Growth Conference on August 11, 2021, at 5:00 PM EDT

2 months ago - Business Wire

Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics' Board of Directors

NEW YORK--(BUSINESS WIRE)---- $PAVM--Prominent global industry executive Aster Angagaw has joined the Board of Directors of PAVmed's subsidiary, Lucid Diagnostics Inc.

2 months ago - Business Wire

CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021

NEW YORK--(BUSINESS WIRE)---- $pavm #earnings--PAVmed to hold business update conference call on August 12, 2021. Company conference call and webcast at EDT 4:30PM EDT.

2 months ago - Business Wire

PAVmed to Hold Business Update Conference Call on August 12, 2021

NEW YORK--(BUSINESS WIRE)---- $pavm #earnings--PAVmed to hold business update conference call on August 12, 2021. Company conference call and webcast at EDT 4:30PM EDT.

2 months ago - Business Wire

3 Biotech Penny Stocks To Watch On Robinhood IPO Day

These Former Penny Stocks Are Turning Heads Ahead Of Robinhood IPO The post 3 Biotech Penny Stocks To Watch On Robinhood IPO Day appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...

Other symbols:GTBP
2 months ago - PennyStocks

Why PAVmed Soared by 12% on Wednesday

The company tapped a respected figure in its industry as a board vice chairman.

2 months ago - The Motley Fool

Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vi...

NEW YORK--(BUSINESS WIRE)---- $pavm--Stanley Lapidus, former Chairman & CEO of Exact Sciences, joins PAVmed subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors.

2 months ago - Business Wire

PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScr...

NEW YORK--(BUSINESS WIRE)---- $PAVM--PAVmed Subsidiary Lucid Diagnostics launches strategic partnership with direct-to-consumer telemedicine company UpScriptHealth.

2 months ago - Business Wire

Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board...

NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today anno...

4 months ago - GlobeNewsWire

PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test

NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that its major ...

4 months ago - GlobeNewsWire

PAVmed Launches Digital Health Company Veris Health Inc.

New subsidiary Veris acquires privately held oncology digital health company Oncodisc Inc.

4 months ago - GlobeNewsWire

PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device

NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, and its major subsidiary Lucid D...

4 months ago - GlobeNewsWire

PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced...

4 months ago - GlobeNewsWire